Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Jan. 21, 2019. Diana DeGette.

Executive Summary

Diagnostics regulatory reform is on the agenda of the US House Energy and Commerce Committee this year. See what Rep. Diana DeGette, D-Colo., a senior member of the committee, who helped introduce the 'Verifying Accurate Leading-edge IVCT Development Act' (VALID Act), a proposed diagnostics reform bill, had to say about device safety here.

“Device safety is always an issue in the committee, although it’s not going to be at the top of our list for the first part of this year. The top thing we really want to do in the Democratic Caucus is to work on making health care more accessible and more affordable for more Americans."—Rep. Diana DeGette, D-Colo., member, US House Energy and Commerce Committee

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT124516

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel